Expression analysis of extracellular microRNA in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis

被引:28
|
作者
Kishore, Amit [1 ]
Navratilova, Zdenka [1 ]
Kolek, Vitezslav [2 ]
Novosadova, Eva [1 ]
Cepe, Klara [3 ]
du Bois, Roland M. [4 ]
Petrek, Martin [1 ]
机构
[1] Palacky Univ, Fac Med & Dent, Dept Pathol Physiol, Hnevotinska 3, Olomouc 77515, Czech Republic
[2] Palacky Univ, Fac Med & Dent, Dept Resp Med & TB, Olomouc, Czech Republic
[3] Palacky Univ, Fac Sci, Olomouc, Czech Republic
[4] Imperial Coll, London, England
关键词
bronchoalveolar lavage; exosomes; microRNA; microvesicles; pulmonary sarcoidosis; ALLERGIC AIRWAY INFLAMMATION; LUNG; EXOSOMES; CELLS; RESPONSES; DISEASE; IMMUNE; MIRNA;
D O I
10.1111/resp.13364
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective MicroRNA (miRNA) are transcriptional regulators implicated in pulmonary sarcoidosis and packaged in extracellular vesicles (EV) during cellular communication. We characterized EV and investigated miRNA expression in bronchoalveolar lavage (BAL) fluid from sarcoidosis patients. Methods EV were characterized for size(s) using dynamic light scattering and transmission electron microscopy (TEM) analysis and protein markers by immunoblotting. Twelve extracellular and 5 cellular miRNA were investigated in BAL from 16 chest X-ray stage-I (CXR-I) and 17 CXR stage-II (CXR-II) sarcoidosis patients. Associations between miRNA and disease characteristics (extrapulmonary involvement, pulmonary function and BAL cell profile) were statistically analysed. Results BAL from sarcoidosis patients contained exosomes and microvesicles (MV) as EV. In these EV, expression of miR-146a (P = 0.007), miR-150 (P = 0.003) and BAL cellular miR-21 (P = 0.01) was increased in CXR-II compared with CXR-I. Other detected EV (miR-21 and miR-26a) and cellular (miR-31, miR-129-3p, miR-146a and miR-452) miRNA were not differentially expressed. The investigated miRNA did not reflect extrapulmonary involvement, but EV miR-146a and miR-150 were negatively correlated with pulmonary function (miR-146a with vital capacity (VC; Spearman's correlation coefficient (r(s)), P = -0.657, 0.007), percent predicted forced expiratory volume in 1 s (FEV1; -0.662, 0.006) and FEV1/forced vital capacity (FVC) ratio (-0.649, 0.008); miR-150 correlated negatively with VC (-0.584, 0.019) and FEV1/FVC ratio (-0.746, 0.001) in CXR-II cases). Conclusion Our data provide evidence that exosomes and microvesicles as extracellular vesicles are present in the bronchoalveolar space of sarcoidosis patients and they differentially express EV miRNA (miR-146a and miR-150), the expression of which correlates negatively with pulmonary function indices. The significance of these findings for disease pathophysiology and clinical course require further investigation.
引用
收藏
页码:1166 / 1172
页数:7
相关论文
共 50 条
  • [1] Protein profiles of bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis
    Kriegova, Eva
    Melle, Christian
    Kolek, Vitezslav
    Hutyrova, Beata
    Mrazek, Frantisek
    Bleul, Annett
    du Bois, Roland M.
    von Eggeling, Ferdinand
    Petrek, Martin
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (10) : 1145 - 1154
  • [2] CYTOKINES IN THE BRONCHOALVEOLAR LAVAGE FLUID OF PATIENTS WITH ACTIVE PULMONARY SARCOIDOSIS
    GIRGIS, RE
    BASHA, MA
    MALIARIK, M
    POPOVICH, J
    IANNUZZI, MC
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (01) : 71 - 75
  • [3] mRNA expression profile of bronchoalveolar lavage fluid cells from patients with idiopathic pulmonary fibrosis and sarcoidosis
    Paplinska-Goryca, Magdalena
    Goryca, Krzysztof
    Misiukiewicz-Stepien, Paulina
    Nejman-Gryz, Patrycja
    Proboszcz, Malgorzata
    Gorska, Katarzyna
    Maskey-Warzechowska, Marta
    Krenke, Rafal
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 (09)
  • [4] LIPIDS IN BRONCHOALVEOLAR LAVAGE FLUID FROM PATIENTS WITH SARCOIDOSIS
    LOW, RB
    DAVIS, GS
    BELL, D
    GIANCOLA, MS
    VACEK, PM
    THORAX, 1987, 42 (12) : 926 - 932
  • [5] Chemokines in the bronchoalveolar lavage fluid of patients with sarcoidosis
    Sugiyama, Y
    Kasahara, T
    Mukaida, N
    Matsushima, K
    Kitamura, S
    INTERNAL MEDICINE, 1997, 36 (12) : 856 - 860
  • [6] UNIFORMITY OF BRONCHOALVEOLAR LAVAGE IN PATIENTS WITH PULMONARY SARCOIDOSIS
    PETERSON, MW
    NUGENT, KM
    JOLLES, H
    MONICK, M
    HUNNINGHAKE, GW
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (01): : 79 - 84
  • [7] Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis
    Wahlström, J
    Berlin, M
    Sköld, CM
    Wigzell, H
    Eklund, A
    Grunewald, J
    THORAX, 1999, 54 (04) : 339 - 346
  • [8] Endostatin and Cathepsin-V in Bronchoalveolar Lavage Fluid of Patients with Pulmonary Sarcoidosis
    Naumnik, W.
    Ossolinska, M.
    Plonska, I.
    Chyczewska, E.
    Niklinski, J.
    LUNG CANCER AND AUTOIMMUNE DISORDERS, 2015, 833 : 55 - 61
  • [9] Imaging Changes and Immune-Checkpoint Expression on T Cells in Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis
    Kotetsu, Yasuaki
    Yanagihara, Toyoshi
    Suzuki, Kunihiro
    Ando, Hiroyuki
    Eto, Daisuke
    Hata, Kentaro
    Arimura-Omori, Masako
    Yamamoto, Yuzo
    Harada, Eiji
    Hamada, Naoki
    BIOMEDICINES, 2021, 9 (09)
  • [10] BRONCHOALVEOLAR LAVAGE FLUID AND SERUM COMPLEMENT ACTIVITY IN PULMONARY SARCOIDOSIS
    LAMBRE, CR
    LEMAHO, S
    DIBELLA, G
    DECREMOUX, H
    ATASSI, K
    BIGNON, J
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1986, 134 (02): : 238 - 242